GD2+ cancer stem cells in triple-negative breast cancer:mechanisms of resistance to breast cancer therapies
作者机构:Department of MedicineTulane University School of MedicineNew OrleansLA 70112USA
出 版 物:《Cancer Drug Resistance》 (癌症耐药(英文))
年 卷 期:2022年第5卷第3期
页 面:721-726页
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
基 金:Krewe de Pink
主 题:Drug resistance breast cancer therapy triple-negative breast cancer cancer stem cells
摘 要:Research has led to the development of tailored treatment options for different cancers in different *** some treatments being able to provide remarkable responses,nearly all current treatments encounter the same issue:***,we discuss our experiences with how breast cancers resist *** focus of our discussion revolves around the cancer stem cell subpopulation and their mechanisms for resistance.